The impact of the COVID-19 pandemic on diagnostic delay of skin cancer: a call to restart screening activities.

The COVID-19 pandemic has led to delays in diagnosis and treatment of patients with skin cancer: presentational delay of patients to the physician, diagnostic referral delay due to restrictions of diagnostic capacities, and/or treatment delay (decision to defer treatment due to increased risk of COVID-19 transmission or health policy restrictions to treatment capacities).